Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has just been approved by the U.S. FDA. It was on Wednesday that the FDA gave the green light to a new therapy to treat a type of lymphoma called Yescarta. The drug will be priced at $373,000 for one administration … Continue reading “Gilead Shares Move Higher After FDA Approves its Cancer Drug”
Biotech & Pharma
Biotech & Pharma
Merck Shares Explode After Citi Upgrade
It was a strong day for pharmaceutical company Merck on Wednesday. The stock's shares started…
October 18, 2017
Biotech & Pharma
Zogenix Shares Double on Epilepsy Treatment Results
Shares of biotech stock Zogenix had an exciting trading day on Friday after the company…
September 29, 2017
Biotech & Pharma
The FDA Has Approved the First Finger Prick-Free Diabetes Device
Millions of Americans may be thrilled to learn that the Food & Drug Administration has…
September 28, 2017
Biotech & Pharma
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
September 25, 2017
Biotech & Pharma
A Test that Can Detect Cocaine in Seconds Using a Fingerprint
Imagine being able to know if someone has been using cocaine recently in just seconds…
September 22, 2017
Biotech & Pharma
This U.S Drug maker Just Said it Will Lay off 20% of Its Workforce
U.S drug maker Alexion announced this week that it would be slashing 20% of its…
September 12, 2017
Biotech & Pharma
This Major Drug Maker Will Cut its Work Force by 9%
Indianapolis-based Eli Lilly announced on Thursday that the company will be cutting almost 9% of…
September 7, 2017
Biotech & Pharma
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
September 4, 2017
Biotech & Pharma
The First FDA Approved Therapy to Fight Leukemia is Here
The FDA has approved a gene therapy treatment for use in the U.S to Novartis…
August 30, 2017
Biotech & Pharma
Pfizer Sees a 50% Rise in Profit with the Help of These Drugs
Top U.S. drug maker Pfizer just reported its second quarter earnings report that beat the…
August 1, 2017
Biotech & Pharma
Vertex Pharmaceuticals Explodes After Announcing These Huge Results
Shares of Vertex Pharmaceuticals sailed higher on Wednesday and were up as much as 21%…
July 19, 2017
Biotech & Pharma
The FDA Has Been Urged to Approve A Cancer Therapy
One of the hardest diseases to fight is cancer, but there's a cutting-edge cancer therapy…
July 14, 2017
Biotech & Pharma
FDA Ask A Major Pharma Company To Remove A Pain Drug From The Market
Endo Pharmaceuticals had a not so good week this week. The FDA has asked the…
June 9, 2017